Canaccord Genuity Group Raises Natera (NASDAQ:NTRA) Price Target to $145.00

Natera (NASDAQ:NTRA – Free Report) had its price target boosted by Canaccord Genuity Group from $130.00 to $145.00 in a research report released on Tuesday, Benzinga reports. The firm currently has a buy rating on the medical research company’s stock. NTRA has been the subject of several other research reports. Jefferies Financial Group began coverage […]

Leave a Reply

Your email address will not be published.

Previous post Evolent Health (NYSE:EVH) Given Buy Rating at Truist Financial
Next post Maravai LifeSciences (NASDAQ:MRVI) Research Coverage Started at Wells Fargo & Company